Navigation Links
BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
Date:5/23/2013

BOTHELL, Wash., May 23, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced its participation at the Terrapinn World Stem Cells & Regenerative Medicine Congress 2013 this week in London.

(Logo: http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO)

Dr. Aby J. Mathew, BioLife's Senior Vice President and Chief Technology Officer, will make a presentation titled "Critical Stability and Biopreservation Considerations for Manufacturing, Storage and Clinical Delivery of Cell and Tissue Products," to the audience of executives and product development managers of commercial regenerative medicine companies. The presentation outlines the risk to clinical and commercial success of cell and tissue products due to stability limitations from the use of non-optimized storage, transport and cryopreservation freeze media. Comparative data illustrating the superior preservation efficacy of BioLife's HypoThermosol® storage and shipping media, and CryoStor® cryopreservation freeze media will be presented on relevant cell and tissue types.

Mike Rice , Chief Executive Officer, commented, "We continue to build traction in the high growth regenerative medicine market, and estimate that more than 65 percent of the presenting companies at this conference have adopted our best in class, clinical grade biopreservation media products.  A key value-added service we provide, which directly translates into expanded product adoption, is the high quality consulting our team offers to prospective and current customers.  Biopreservation outcomes such as cell and tissue shelf life, viability and recovery can greatly impact commercial potential.  The combination of the efficacy and quality of our proprietary platform technology, along with our expert technical consulting services, is now recognized and highly valued in the development and commercialization of regenerative medicine products and therapies."

The regenerative medicine market is expected to grow to more than $35 billion by 2019, according to TriMark Publications' recently published "Regenerative Medicine Markets" report.  BioLife's addressable portion of the market is the demand for reagents used to store, ship and freeze source material and manufactured doses of cell-based products and therapies.

For a list of upcoming events, please visit http://biolifesolutions.com/cell-therapy/category/events/.

About BioLife SolutionsBioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues.  The Company's proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce biopreservation-induced cell damage and death.  BioLife's enabling technology provides academic and clinical researchers, and commercial companies significant improvements in post-thaw cell, tissue, and organ viability and function.  For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact.  Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission.  BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.  Media Relations:

Investor Relations:Len Hall

Matt ClawsonAllen & Caron Inc

Allen & Caron Inc(949) 474-4300

(949) 474-4300len@allencaron.com

matt@allencaron.com
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioLife Solutions Completes First $1 Million Revenue Quarter
2. BioLife Solutions Appoints Rick Stewart To Board of Directors
3. BioLife Solutions Announces 2012 Full Year Results; 10th Consecutive Quarter of Record Revenue
4. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
5. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
6. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
7. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
8. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
9. Ablative Solutions Completes $5.3M Series A Financing
10. DATATRAK Expands CDISC Registered Solutions Provider Standards
11. MedNet Solutions to Unveil Innovative New iMedNet EDC Features at The 48th DIA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2019)... ... June 24, 2019 , ... A new report ... laboratory information management system, or LIMS. , Not only that, an estimated 44% ... a new report, " The 2019 Market for Laboratory Software LIMS, CDS, MSS ...
(Date:6/24/2019)... ... June 24, 2019 , ... ... Boston, Massachusetts-based digital experience agency, is pleased to announce that its annual ... a Communicator Award of Excellence https://www.communicatorawards.com/winners/list/?event=1026&category=1915&award=8 in the Collateral category ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... Treatment Centers Columbus East, its first opioid treatment program (OTP) in Ohio ... clinic, located at 1805 E. Main Street, Columbus, is now accepting patients. ...
Breaking Medicine Technology:
(Date:6/20/2019)... ... June 20, 2019 , ... ... and IT services, announced that Angel Rosa has been appointed as Senior Vice ... in developing and implementing new services, growing and nurturing high performing teams, and ...
(Date:6/20/2019)... OKLAHOMA CITY, Okla. (PRWEB) , ... June 20, ... ... provider, is pleased to announce their partnership with Physical Therapy Solutions in Lawton, ... Street, Suite C, the clinic is the group’s 28th clinic in the state. ...
(Date:6/19/2019)... ... June 19, 2019 , ... ... institutions, media, and government joined Global Health Council (GHC) and Global Water ... access to water, sanitation, and hygiene (WASH) in healthcare facilities. , ...
(Date:6/19/2019)... ... , ... CEO Steven C. Bilt of Smile Brands Inc. has won a ... Glassdoor , one of the world’s largest job and recruiting sites, released its annual ... countries throughout North America and parts of Europe. , Smile Brands, a leading dental ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... A ... in the United States, has filed class action lawsuits in 34 of the ... defendants in the class actions are an array of pharmaceutical manufacturers, distributors and retailers, ...
Breaking Medicine News(10 mins):